Farnesyltransferase inhibitor
This page covers all Farnesyltransferase inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Farnesyltransferase.
Targets
Phase 3 pipeline (2)
- Placebo Lonafarnib · Eiger BioPharmaceuticals · Oncology
Lonafarnib inhibits farnesyltransferase, blocking the post-translational modification of proteins involved in cell proliferation and survival. - Tipifarnib;Zarnestra; R115777 · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. · Oncology
Tipifarnib is a farnesyltransferase inhibitor that blocks the farnesylation of Ras proteins, which are involved in cell signaling and proliferation.